Cancer: ARCON laments poor cancer management in Nigeria

187

President of Association of Radiation and Clinical Oncologist of Nigeria (ARCON), Dr Nwamaka Lasebikan, has expressed concern over the rise in cancer incidences and the poor management in the country.

Lasebikan made this known in a statement after the conclusion of a one day symposium on Friday in Enugu themed “Optimising the Standard of Care for Breast Cancer in Nigeria”.

The president said the symposium sought the way forward to cancer care in Nigeria.

She also expresses concern over the slow implementation of the National Comprehensive Cancer Network (NCCN) guidelines in Nigeria.

She said that the NCCN guideline was recently adopted by the Federal Ministry of Health as the standard of care for cancer management in Nigeria.

She however, expressed worry over the rising incidence of cancer and its poor outcome even with treatment attributing it, in part, to poor standardisation of evidence based care.

“There is the need to close the care gap and generally improve both the quality of life and the clinical outcomes in patients with breast cancer.

“This can be achieved through widespread implementation of the harmonised guideline to ensure that breast cancer care is optimal and standardised across Nigeria and Africa as a whole,’’ she said.

The Minister of Health, Dr Osagie Ehanire, represented by Mr Uchechukwu Nwokwu, Associate Director, National Cancer Control Program, re-emphasised government’s commitment to fighting cancer.

“Government remains committed to providing adequate access to standardised cancer care in the country through programmes such as the ongoing Cancer Health Funds.

“The Federal Government’s adoption of the NCCN Harmonised Guidelines and the need for healthcare workers to abide by it remains key,” Ehanire said.

According to reports, the symposium featured several lectures from seasoned experts in oncology.

Reports also has it that topics such as standardising breast cancer care through guideline adherence, some predictive and prognostic biomarkers in decision making for breast cancer were highlighted.

Stakeholders in attendance at the symposium were; the representatives from the Minister of Health, the Enugu State Commissioner for Health, the Nigerian Medical Association (NMA)Chief Medical Director of UNTH, the Medical Women Association of Nigeria (MWAN).
The West African College of Surgeons among other professors and Oncology consultants were also present.

NAN)